Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Not getting a COVID-19 vaccine could lead to preterm birth in pregnant women, new study shows

Por: The Times-Tribune Nation December 07, 2023

thumbnail

COVID-19 infection can lead to preterm birth, a study published last week in the journal PNAS shows, but getting vaccinated protects against it.... + full article



Similar News

COVID vaccine prevented thousands of premature births in pandemic—study

Newsweek USA Health November 27, 2023

thumbnailCOVID-19 infection during pregnancy increases a child's risk of being born prematurely, a new study has found. But this impact disappears after maternal vaccination, suggesting that the vaccine may have prevented thousands of premature births.Preterm birth is the leading... + más

US births in 2022 didn't return to pre-pandemic levels | WPLG Local 10

US births in 2022 didn't return to pre-pandemic levels | Associated Press


Infant’s death prompts FDA warning on probiotics

WGN-TV USA Nation October 27, 2023

thumbnail() — An infant’s death has prompted the Food and Drug Administration (FDA) to issue a warning to medical professionals about giving probiotics to hospitalized preterm infants. The FDA said that  sepsis and later died after the infant was given a probiotic while in hospital... + más

Ozona Organics Recalls Probiotics For Human, Animal Use | RTTNews

FDA investigating baby's death linked to probiotic given by hospital | CBS News


FDA pulls approval for only drug meant to reduce preterm birth

The Hill USA Health April 08, 2023

thumbnailThe Food and Drug Administration (FDA) is pulling its approval of the only drug on the market for reducing the risk of preterm birth in pregnant women, citing a lack of effectiveness demonstrated by the treatment. The FDA approved Makena in 2011 under its accelerated approval... + más

US gets D+ grade for rising preterm birth rates, new report finds | CNN

FDA panel recommends pulling preterm birth drug from the market | The Boston Globe


US gets D+ grade for rising preterm birth rates, new report finds

CNN USA Health November 15, 2022

thumbnailCNN  —  The rate of premature birth in the United States is climbing, according to the infant and maternal health nonprofit March of Dimes. On Tuesday, the organization released its , which involves a newly updated calculation system. Taking an in-depth look at premature... + más

FDA panel recommends pulling preterm birth drug from the market | The Boston Globe

F.D.A. Panel Recommends Pulling Preterm Birth Drug From the Market | The New York Times


You Can Do Everything 'Right' and Still Have a Preterm Birth

Time USA Life October 28, 2022

thumbnailEvery day, as I rush to preterm deliveries on the labor floor of my safety-net hospital and work beside incubators and clear plastic hospital bassinets, one of my patients’ mothers confides to me her belief that if she had only done that one thing differently during pregnancy,... + más

US gets D+ grade for rising preterm birth rates, new report finds | CNN

FDA panel recommends pulling preterm birth drug from the market | The Boston Globe


F.D.A. Panel Recommends Pulling Preterm Birth Drug From the Market

The New York Times USA Health October 20, 2022

thumbnailA Food and Drug Administration advisory committee on Wednesday recommended removing the drug Makena from the market, after years of study showed the fast-tracked drug had failed to prevent preterm births.Makena has been in use for 11 years, and the panel’s vote was widely of... + más

FDA panel recommends pulling preterm birth drug from the market | The Boston Globe

FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth | CNBC


FDA panel recommends pulling preterm birth drug from the market

The Boston Globe USA Nation October 20, 2022

thumbnailA Food and Drug Administration advisory committee on Wednesday recommended removing the drug Makena from the market, after years of study showed the fast-tracked drug had failed to prevent preterm birth.Makena has been in use for 11 years, and the panel’s vote was widely... + más

F.D.A. Panel Recommends Pulling Preterm Birth Drug From the Market | The New York Times

FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth | CNBC



About iurex | Privacy Policy | Disclaimer |